Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Other Working Capital Changes (2023 - 2025)

Zenas BioPharma has reported Other Working Capital Changes over the past 3 years, most recently at -$1.7 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$1.7 million for Q4 2025, down 120.8% from a year ago — trailing twelve months through Dec 2025 was -$902000.0 (down 111.71% YoY), and the annual figure for FY2025 was -$902000.0, down 111.71%.
  • Other Working Capital Changes for Q4 2025 was -$1.7 million at Zenas BioPharma, down from $1.6 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for ZBIO hit a ceiling of $8.2 million in Q4 2024 and a floor of -$1.7 million in Q4 2025.
  • Median Other Working Capital Changes over the past 3 years was -$151000.0 (2023), compared with a mean of $738666.7.
  • Biggest five-year swings in Other Working Capital Changes: surged 5514.57% in 2024 and later crashed 719.15% in 2025.
  • Zenas BioPharma's Other Working Capital Changes stood at -$151000.0 in 2023, then surged by 5514.57% to $8.2 million in 2024, then tumbled by 120.8% to -$1.7 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$1.7 million (Q4 2025), $1.6 million (Q3 2025), and -$1.2 million (Q2 2025) per Business Quant data.